A more sensitive pressure-based index to estimate collateral blood supply in case of coronary three-vessel disease

Majid Harmouche1, Mahmoud Maasrani, Hervé Corbineau

  • 1Department of Thoracic and Cardiovascular Surgery, Rennes Hospital Center, France.

Medical Hypotheses
|May 29, 2012
PubMed

Insights

New collateral flow index improves assessment of blood supply to heart muscle during coronary artery disease. This aids surgical planning and patient outcomes by more precisely evaluating heart tissue preservation.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Coronary artery occlusion triggers the recruitment of anastomotic vessels, forming collateral circulation.
  • Collateral circulation is vital for myocardial preservation in ischemic regions before reperfusion.
  • Accurate collateral flow estimation is critical for surgical bypass planning and treatment outcomes.

Purpose of the Study:

  • To introduce a novel index for evaluating collateral flow with enhanced sensitivity to distal pressure.
  • To improve the precision in describing the role of collateral circulation in coronary artery disease.
  • To demonstrate the utility of the proposed index using clinical pressure measurements.

Main Methods:

  • Utilized pressure measurements from patients with severe coronary artery disease.
  • Defined the existing Collateral Flow Index (CFI) based on aortic, distal, and central venous pressures.
  • Proposed a new index designed to be more sensitive to pressure distal to thrombosis (P(w)).

Main Results:

  • The proposed index offers greater sensitivity to the pressure distal to the occlusion (P(w)).
  • This enhanced sensitivity allows for a more precise description of collateral flow's role.
  • Clinical data from patients with severe coronary disease were used for illustration.

Conclusions:

  • A new index provides a more precise assessment of collateral flow compared to the traditional CFI.
  • This improved evaluation is crucial for optimizing surgical bypass strategies in coronary artery disease.
  • The findings support the use of this novel index for better patient management and treatment planning.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...